Acro Biomedical (ACBM) Net Cash Flow Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 2,009.78% |
| Jun 30, 2025 | -129.03% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 92.23% |
| Sep 30, 2024 | -138.07% |
| Jun 30, 2024 | -67.13% |
| Mar 31, 2024 | 95.93% |
| Dec 31, 2023 | 71.99% |
| Sep 30, 2023 | -85.52% |
| Jun 30, 2023 | 100.68% |
| Mar 31, 2023 | -102.11% |
| Dec 31, 2022 | 82.60% |
| Sep 30, 2022 | 106.71% |
| Jun 30, 2022 | -280.79% |
| Mar 31, 2022 | 4,108.15% |
| Sep 30, 2021 | -26,936.00% |
| Jun 30, 2021 | 1,963.82% |
| Mar 31, 2021 | -35.88% |
| Sep 30, 2020 | 99.38% |
| Jun 30, 2020 | 72.56% |
| Mar 31, 2020 | 126.15% |
| Dec 31, 2019 | -101.54% |
| Sep 30, 2019 | -942.26% |
| Jun 30, 2019 | 92.00% |
| Mar 31, 2019 | -108.03% |
| Dec 31, 2018 | 228.98% |
| Sep 30, 2018 | -109.42% |
| Mar 31, 2018 | 1,671.91% |
| Dec 31, 2017 | -19,807.04% |
| Sep 30, 2017 | 483.12% |
| Mar 31, 2017 | -260.97% |
| Dec 31, 2016 | 98.75% |
| Sep 30, 2016 | -532.94% |